These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5402493)

  • 1. [Treatment of threatened abortion with high doses of progesterone].
    Spanio P; Mandruzzato GP
    Minerva Ginecol; 1969 May; 21(10):681-2. PubMed ID: 5402493
    [No Abstract]   [Full Text] [Related]  

  • 2. [High doses of progesterone in the therapy of hormonal abortion and in the prevention of various types of pregnancy interruption].
    Morra C; Carazzone PF; Lanza A
    Minerva Ginecol; 1969 May; 21(10):699-701. PubMed ID: 5402501
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy.
    Palagiano A; Bulletti C; Pace MC; DE Ziegler D; Cicinelli E; Izzo A
    Ann N Y Acad Sci; 2004 Dec; 1034():200-10. PubMed ID: 15731312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contractibility of the human uterus and the hormonal situation. Studies on therapy with progesterone in pregnancy].
    Mentasti P; Gagliardi F; Rigon D
    Minerva Ginecol; 1969 May; 21(10):685-7. PubMed ID: 5402495
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progesterone in large doses: metabolic and therapeutic aspects].
    Montanino G; Vizzone A
    Minerva Ginecol; 1966 Aug; 18(16):880-4. PubMed ID: 5989252
    [No Abstract]   [Full Text] [Related]  

  • 6. [The action of progesterone on uterine motoricity. Therapeutic deductions].
    Crainicianu A
    Rev Fr Gynecol Obstet; 1967 Jun; 62(6):295-301. PubMed ID: 5630242
    [No Abstract]   [Full Text] [Related]  

  • 7. Physiology should be supported with evidence in progesterone administration for threatened miscarriage -- authors' reply.
    Kalinka J; Szekeres-Bartho J; Kalinka J
    Am J Reprod Immunol; 2005 Dec; 54(6):397. PubMed ID: 16305666
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study of allylestrenol progesterone action on the cervical mucus and the vaginal cytology in threatened abortion, Preliminary report].
    Matute Rafray MM; Ruiz Velasco V; Conde BI; Lozano C
    Ginecol Obstet Mex; 1971 Dec; 30(182):671-9. PubMed ID: 5138659
    [No Abstract]   [Full Text] [Related]  

  • 9. [The pharmacodynamic action of caffeine. Deductions in clinical obstetrics].
    Crainicianu A
    Minerva Ginecol; 1971 Dec; 23(23):984-9. PubMed ID: 5167813
    [No Abstract]   [Full Text] [Related]  

  • 10. Progesterone depot in threatened abortion.
    Camilleri AP; Gauci NM
    Obstet Gynecol; 1971 Dec; 38(6):893-5. PubMed ID: 5166466
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the problems of progesterone treatment of threatened abortion].
    Steinhoff R
    Dtsch Gesundheitsw; 1967 Aug; 22(32):1502-6. PubMed ID: 5590026
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of 2 therapeutic schemes in threatened premature labor].
    Di Renzo GC; Alessandrini G; Zardini E
    Minerva Ginecol; 1981 Sep; 33(9):841-50. PubMed ID: 7322428
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion.
    Kalinka J; Szekeres-Bartho J
    Am J Reprod Immunol; 2005 Apr; 53(4):166-71. PubMed ID: 15760377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of progesterone in the 1st trimester of pregnancy and in the treatment of threatened abortion].
    Bengtsson LP
    Rev Fr Gynecol Obstet; 1968 Mar; 63(3):73-81. PubMed ID: 5761334
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnostic value of plasma progesterone in nonendocrine incipient abortions in the 1st trimester].
    Rachev E
    Akush Ginekol (Sofiia); 1983; 22(4):270-3. PubMed ID: 6670697
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prognosis and treatment of threatened abortion. E. Management of the danger of abortion].
    Leng JJ
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):90-4. PubMed ID: 7451888
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intacellin for the management of threatened abortion].
    Suzumura M; Mitsui T; Mihara M; Saji M; Ochiai T
    Sanfujinka No Jissai; 1969 Nov; 18(12):1102-5. PubMed ID: 5395799
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of abortion with progesterone and etiology of abortion].
    Sakurabayashi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1970 Jan; 22(1):69-72. PubMed ID: 5462320
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of a natural progesterone associated with a synthetic progestogen and vitamin E in the treatment of threatened abortion and premature labor].
    Panariello S
    Arch Ostet Ginecol; 1970 Dec; 75(6):492-506. PubMed ID: 5526026
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of hormonal treatment of threatened abortion].
    Skolicki Z
    Folia Med Cracov; 1980; 22(1):137-49. PubMed ID: 6254862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.